LIFECYCLE STAGE 13 / 14

Post-Market Clinical Follow-up (PMCF)

Targeted collection of post-market clinical data to confirm safety/performance and address remaining clinical uncertainties.

Product evidence journey12
1234567891011121314
13PMCF
IN ONE SIMPLE SENTENCE

Targeted collection of post-market clinical data to confirm safety/performance and address remaining clinical uncertainties.

What is this service?

PMCF is a post-market activity that specifically generates new clinical data about the device to confirm that safety and performance remain acceptable during real-world use and over time.

GOAL

Address remaining clinical evidence gaps, confirm long-term performance and study populations that were under-represented before market entry.

What can MICT do here?

Design the PMCF plan, choose methods such as surveys, registries, follow-up or studies, collect/analyze data and prepare the PMCF Evaluation Report.

TYPICAL INPUTS

What we usually need to start

  • CER and clinical evidence gaps
  • PMS and complaints
  • Risk management
  • Market data
  • Remaining clinical questions
TYPICAL OUTPUTS

What this stage can deliver

  • PMCF plan
  • PMCF protocol or questionnaire
  • Follow-up data
  • Subgroup and signal analyses
  • PMCF Evaluation Report
  • Recommendations to update CER, PMS or risk management

Important terms in plain language

PMCF
Post-Market Clinical Follow-up; clinical follow-up of a device after market entry.
Follow-up
Tracking users or patients over time.
Registry
A structured database that follows a defined patient or device-user population over time.
PMCF Plan
The plan defining which post-market clinical questions will be addressed and how.
PMCF Evaluation Report
The report that summarizes and interprets PMCF activities and findings.
SIMPLE EXAMPLE — BLOOD PRESSURE MONITOR

If PMS shows that older users repeat measurements more often, PMCF can focus on this subgroup and investigate the reason.